DigiPharma Connect 2027 » Day 3 Wednesday March 10th, 2027

TURNING ENGAGEMENT INTO OUTCOMES

8:00 am - 8:40 am BREAKFAST

8:40 am - 8:45 am DAY THREE OPENING REMARKS

8:45 am - 8:55 am CHAIRPERSON’S REMARKS

8:55 am - 9:15 am KEYNOTE FIRESIDE CHAT: Access Is Brand Strategy: Why The Commercial Journey Cannot End At The Prescription

The best marketing experience means little if a patient reaches the pharmacy and cannot access or afford treatment. Market access and patient services must become part of the customer experience rather than a separate downstream function.

• Integrating affordability and access considerations into journey design

• Establishing shared accountability across brand, market access, patient services, digital, and analytics for the post-prescription experience

• Communicating support options clearly without adding customer complexity

• Quantifying how affordability and access friction affect initiation, abandonment, persistence, customer trust, and ultimately brand performance

9:15 am - 9:45 am PANEL DISCUSSION: The New Specialty Commercial Model: Winning When Every Patient Counts

Specialty and rare-disease therapies require commercial models built around small populations, complex care pathways, specialist networks, access barriers, and high-value individual patients. Traditional reach-and-frequency approaches are poorly suited to a world where finding and supporting the right patient matters more than reaching the largest audience.

• Building commercial strategies around precision rather than scale

• Connecting patient finding, HCP education, access, and support into one model

• Using data responsibly to identify gaps across complex care pathways

• Redefining commercial performance when small patient populations make identification, initiation, access, persistence, and individual patient outcomes more meaningful than traditional reach metrics

9:45 am - 10:15 am BUSINESS MEETINGS

10:20 am - 10:50 am BUSINESS MEETINGS

10:50 am - 11:20 am BUSINESS MEETINGS

9:45 am - 10:15 am PRESENTATION Beyond Adherence: Designing For Long-Term Treatment Persistence

Getting a patient started on therapy is only one step toward a successful outcome. Commercial teams must better understand the emotional, financial, clinical, and logistical factors that influence whether patients remain on treatment.

• Identifying why patients discontinue or interrupt therapy

• Using behavioral and real-world insights to recognize persistence risk earlier

• Coordinating education, support, and access interventions throughout treatment

• Designing engagement around long-term patient needs rather than campaign timelines

10:20 am - 10:50 am PRESENTATION Beyond The Patient Influencer: The Rise Of The Healthcare Creator

Healthcare influence now extends beyond traditional celebrity and patient partnerships to clinicians, scientists, caregivers, advocates, and highly specialized creators. Brands must understand when these voices build credibility, where risk emerges, and how influence can be measured beyond follower count.

• Mapping the expanding healthcare creator ecosystem

• Selecting partners based on authority, relevance, and trust rather than reach alone

• Building compliant relationships without destroying authenticity

• Measuring creator impact across awareness, education, trust, and action

10:50 am - 11:20 am Business Meetings

11:20 am - 11:40 am FIRESIDE CHAT: Your CRM Was Built For Yesterday's Customer: What's Next?

Traditional CRM systems were designed around known customers, historical interactions, and predetermined workflows. As customer signals become richer and engagement becomes more dynamic, organizations must determine whether their existing commercial infrastructure can keep up.

• Identifying where traditional CRM architectures and workflows constrain real-time customer engagement

• Determining how behavioral, contextual, interaction, and AI-derived signals should connect with existing customer data

• Moving from passive systems of record toward infrastructure capable of recommending and enabling intelligent action

• Deciding what should remain in CRM, what requires new capabilities, and how to modernize without creating another fragmented commercial technology stack

11:40 am - 12:10 pm BUSINESS MEETINGS

11:40 am - 12:10 pm PRESENTATION The HCP Attention Recession: What Actually Earns A Clinician's Time?

HCPs face growing demands on their attention while brands continue adding emails, portals, media, rep interactions, and educational content. Winning engagement in 2027 will require delivering enough value that clinicians actively choose to spend time with the brand.

• Understanding what HCPs consider genuinely valuable engagement

• Reducing repetitive and low-value communications across channels

• Personalizing around clinical need rather than marketing preference

• Replacing volume-based engagement metrics with measures of attention quality, clinical relevance, behavior change, and incremental value

12:10 pm - 12:30 pm CLOSING FIRESIDE CHAT: From Patient Support Program To Patient Operating System

Patient support programs often exist as disconnected services surrounding a therapy rather than one integrated experience. The opportunity is to connect education, onboarding, access, adherence, and ongoing support into a relationship that evolves with the patient.

• Connecting education, onboarding, affordability, access, adherence, and ongoing support into a unified patient experience

• Creating a shared intelligence layer that recognizes changing patient needs and coordinates the appropriate next intervention

• Establishing interoperability and ownership across brand, patient services, access, technology, and external partners

• Measuring the system against initiation, time-to-therapy, persistence, patient experience, and long-term outcomes rather than individual program activity

Day 3 Wednesday March 10th, 2027